
Reset all filters
01 1Knight Therapeutics Inc
02 14Paladin Labs Inc.
03 8Smart & Biggar
Reset all filters
01 72268187
02 12487577
03 72658585
04 82770180
Reset all filters
01 15BUPRENORPHINE HYDROCHLORIDE
02 8BUPRENORPHINE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE DIHYDRATE
Reset all filters
01 22FILM, SOLUBLE
02 1IMPLANT
Reset all filters
01 72017-10-16
02 12023-06-02
03 72027-07-23
04 82030-08-05
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Brand Name : BELBUCA
Patent Number : 2268187
Filing Date : 1997-10-16
Strength per Unit : 75 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Brand Name : BELBUCA
Patent Number : 2658585
Filing Date : 2007-07-23
Strength per Unit : 75 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Brand Name : BELBUCA
Patent Number : 2268187
Filing Date : 1997-10-16
Strength per Unit : 150 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Brand Name : BELBUCA
Patent Number : 2658585
Filing Date : 2007-07-23
Strength per Unit : 150 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Brand Name : BELBUCA
Patent Number : 2268187
Filing Date : 1997-10-16
Strength per Unit : 300 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Brand Name : BELBUCA
Patent Number : 2658585
Filing Date : 2007-07-23
Strength per Unit : 300 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Brand Name : BELBUCA
Patent Number : 2268187
Filing Date : 1997-10-16
Strength per Unit : 450 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Brand Name : BELBUCA
Patent Number : 2658585
Filing Date : 2007-07-23
Strength per Unit : 450 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Brand Name : BELBUCA
Patent Number : 2268187
Filing Date : 1997-10-16
Strength per Unit : 600 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-10-16
Date Granted : 2007-06-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Brand Name : BELBUCA
Patent Number : 2658585
Filing Date : 2007-07-23
Strength per Unit : 600 mcg
Dosage Form : FILM, SOLUBLE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-07-23
Date Granted : 2011-03-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF